High-yield novel leech hyaluronidase to expedite the preparation of specific hyaluronan oligomers
Research article published in Scientific reports (2014)
Abstract
Hyaluronidases (HAases), particularly leech HAases, have attracted intense attention due to their broad applications in medical treatments and great potential for the enzymatic production of hyaluronan oligosaccharides. However, little is known about this third interesting family of HAases. Here, we applied the random amplification of cDNA ends polymerase chain reaction (RACE-PCR) approach to identify the first leech HAase-encoding gene. By combining protein engineering and high-density culture, we achieved high-level production (8.42 × 10(5) U ml(-1)) in the yeast Pichia pastoris secretory expression system. Compared with the commercial bovine testicular HAase, the recombinant leech HAase exhibited superior enzymatic properties. Furthermore, analysis of the hydrolytic process suggested that this novel enzyme adopts a nonprocessive endolytic mode, yielding a narrow-spectrum of specific HA oligosaccharides with different incubation times. Large-scale production of this novel leech HAase will not only greatly promote medical applications but also facilitate the enzymatic production of specific HA oligosaccharides.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Using RACE-PCR, researchers identified the first leech hyaluronidase-encoding gene and expressed it in Pichia pastoris at 8.42 × 10^5 U/ml; the recombinant enzyme showed superior enzymatic properties to bovine testicular hyaluronidase and yielded specific hyaluronan oligosaccharides.
Why This Matters for Hirudotherapy
This study identified the first leech hyaluronidase-encoding gene using RACE-PCR and achieved high-level recombinant production (8.42 × 10⁵ U/ml) in the yeast Pichia pastoris. The recombinant leech hyaluronidase exhibited superior enzymatic properties compared with commercial bovine testicular hyaluronidase and operated via a nonprocessive endolytic mode, yielding specific hyaluronan oligosaccharides with different incubation times. This work characterizes a leech-derived enzyme with noted broad medical applications, contributing to understanding of the leech secretome's enzymatic components. This is a biotechnology study focused on enzyme production and characterization; it does not involve hirudotherapy, clinical application, or therapeutic outcomes in patients.
Citation
Reference (Vancouver style)
Jin P, Kang Z, Zhang N, Du G, Chen J. High-yield novel leech hyaluronidase to expedite the preparation of specific hyaluronan oligomers. Sci Rep. 2014;4:4471. doi:10.1038/srep04471. PMID: 24667183
Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.
Added to ASH library: March 18, 2026 · Site last updated: November 1, 2026